Utrecht, Netherlands

Mario Van Der Stelt


 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Mario Van Der Stelt

Introduction

Mario Van Der Stelt, an innovative inventor based in Utrecht, Netherlands, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Van Der Stelt is recognized for his work in developing novel compounds that target specific diseases, particularly those mediated by RORgammaT.

Latest Patents

Among his latest patent inventions are RORgammaT inhibitors, which are designed as compounds that can be utilized in the treatment of RORgammaT-mediated diseases or conditions. Specifically, the patents relate to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. This innovation has the potential to impact therapeutic approaches significantly.

Career Highlights

Throughout his professional journey, Mario Van Der Stelt has worked with both Merck Sharp & Dohme Corporation and Merck Sharp & Dohme B.V. His tenure with these companies highlights his expertise and the trust placed in him to lead critical research initiatives.

Collaborations

In addition to his impressive patent portfolio, Van Der Stelt has collaborated with notable colleagues, including Willem Frederik Johan Karstens and Jos Cals. Together, they have shared insights and contributed to advancements in pharmaceutical research.

Conclusion

Mario Van Der Stelt is a dedicated inventor whose contributions have the potential to enhance therapeutic outcomes in various diseases. His patents on RORgammaT inhibitors reflect his commitment to innovation and the advancement of medical science. With a strong foundation in pharmaceutical research and collaboration, Van Der Stelt continues to pave the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…